Pichl Daniel's Form 4 filing
SpringWorks Therapeutics, Inc.SWTX · filed Feb 12, 2025
- Accession no.
- 0001104659-25-012365
- Filed
- Feb 12, 2025
- Trade date
- Feb 10, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.62M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pichl DanielCIK 0001819465 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | MOption exerciseAcquired | +13,750 | $27.64 | +$380,050 | 64,512 | Direct | |
| Feb 10, 2025 | Common Stock | MOption exerciseAcquired | +16,000 | $27.64 | +$442,240 | 80,512 | Direct | |
| Feb 10, 2025 | Common Stock | SSaleDisposed | −13,750 | $53.02F2 | −$729,025 | 66,762 | Direct | |
| Feb 10, 2025 | Common Stock | SSaleDisposed | −9,000 | $54.25F3 | −$488,250 | 57,762 | Direct | |
| Feb 10, 2025 | Common Stock | SSaleDisposed | −7,000 | $57.15F4 | −$400,050 | 50,762 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Common Stock | MOption exerciseDisposed | −13,750 | $0.00 | $0 | 31,250 | Direct | |
| Feb 10, 2025 | Common Stock | MOption exerciseDisposed | −16,000 | $0.00 | $0 | 32,750 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.515. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.